Flexion Therapeutics — Q2 2019 Earnings Presentation
7 slides from Flexion Therapeutics's earnings presentation, Aug 6, 2019
Slide 1: Commercial Metrics Overview
Commercial Metrics Overview August 6, 2019 Exhibit 99.2
Slide 2: Commercial Metrics Overview
Commercial Metrics Overview ZILRETTA® net sales of $17.0 million in the second quarter of 2019 We have called on almost all of our 4,400 target accounts 2,733 accounts have purchased ZILRETTA, as of June 30, 2019; up from 2,247, as of March 31, 2019 2,004 accounts have re-ordered ZILRETTA (73% of ac
Slide 3: ZILRETTA Net Sales Quarterly
ZILRETTA Net Sales Quarterly Note: Flexion recognizes ZILRETTA sales upon receipt of product by specialty distributors and pharmacies.
Slide 4: Distribution of Accounts by ZILRETTA Purchases Cumulative
Distribution of Accounts by ZILRETTA Purchases Cumulative Note: Flexion recognizes ZILRETTA sales upon receipt of product by specialty distributors and pharmacies; accounts purchase ZILRETTA directly from these specialty distributors and pharmacies.
Slide 5: Distribution of ZILRETTA Purchases by Accounts Cumulative
Note: Flexion recognizes ZILRETTA sales upon receipt of product by specialty distributors and pharmacies; accounts purchase ZILRETTA directly from these specialty distributors and pharmacies. Distribution of ZILRETTA Purchases by Accounts Cumulative
Slide 6: ZILRETTA Purchases by New and Existing Accounts Cumulative
ZILRETTA Purchases by New and Existing Accounts Cumulative Note: Flexion recognizes ZILRETTA sales upon receipt of product by specialty distributors and pharmacies; accounts purchase ZILRETTA directly from these specialty distributors and pharmacies.
Slide 7: Transformative Medicine... Where It Matters
clevion Transformative Medicine... Where It Matters